-
PerkinElmer to Acquire Caliper Life Sciences for $600 Million
Sep 8, 2011, 07:20 AM by Michael CroftFull storyBio-IT World | PerkinElmer has signed an agreement to acquire its Massachusetts neighbor, Caliper Life Sciences, for about $600 million. The acquisition is PerkinElmer's seventh this year, including CambridgeSoft and Geospiza.
-
How Amira Beat the Odds
Sep 8, 2011, 03:55 AM by Michael CroftXconomy | Amira Pharmaceuticals sold an early stage drug to Bristol-Myers for $325 million upfront cash plus milestone payments. So how did they do it?Full story -
Quebec’s Genizon Biosciences Closes its Doors
Sep 7, 2011, 14:35 PM by Michael CroftBio-IT World | EXCLUSIVE -- Genizon Biosciences, the Montreal-based genomics company seeking the genes responsible for inherited disorders in the Quebec founder population, has ceased operations. The firm was put into receivership by the Superior Court of Quebec in July.Full story -
GWAS Reveals Genetic Variance in Metabolism
Sep 6, 2011, 00:50 AM by Michael CroftBio-IT World | A study published last week in Nature establishes a strong association between biochemical levels and the genetics of an individual. Researchers looked at genetic variation in human metabolism and discovered 37 new variants associated with concentrations of metabolites in the blood. The Genome Wide Association Study (GWAS) was carried out by researchers at Helmholtz Zentrum Munchen Institute in Munich, Germany, the Wellcome Trust Sanger Institute, King’s College and Metabolon.Full story -
Taking the Cloud from Amazon
Sep 6, 2011, 00:50 AM by Michael CroftCNET | Taking market share from Amazon Web Services would be tough, but not impossible, and there are a few ways to do it. Competitors could compete head-to-head, change the rules of the game, or join an open cloud ecosystem.Full story -
Building Biohacker Tools for Garage Labs
Sep 2, 2011, 00:00 AM by Michael CroftWired | CoFactor is a new company that aims to enable "biohackers"--individuals with pop-up garage labs who want to do biology outside of traditional environments.Full story -
How to Build Successful Biotech Startups
Sep 1, 2011, 00:30 AM by Michael CroftXconomy | MIT's Bob Langer has founded about 24 companies and has 800 patents issued or pending. Langer talks about turning foundation and government money into startup successes.Full story -
Ed Liu on Singapore Science and Jackson Lab Priorities
Aug 29, 2011, 15:30 PM by Michael CroftFull storyBio-IT World | "Singapore needs a refresh, and perhaps I do as well,” says Edison Liu, the CEO-elect of The Jackson Laboratory (JAX), who reflected last week on his decade in Singapore and his priorities for his return next year to the US at the legendary mammalian genetics institute.
-
Sequencing Shows World's Cholera Comes From Single Source
Aug 29, 2011, 00:30 AM by Michael CroftBBC | By sequencing the genomes of 154 cholera bacteria samples, researchers at the Sanger Institute have identified a single global source: the Bay of Bengal.Full story -
Of Mice and Men: Edison Liu Leaves Singapore to Head Jackson Laboratory
Aug 26, 2011, 08:55 AM by Michael CroftBio-IT World | Edison Liu, arguably the most prominent medical researcher in Singapore and the two-term president of the Human Genome Organization (HUGO), is returning to the United States after ten years to become the new president and CEO of The Jackson Laboratory in Bar Harbor, Maine.Full story -
UK Launches Cancer Genomics Project
Aug 26, 2011, 01:30 AM by Michael CroftNature News | The UK will launch a personalized medicine pilot project next month. The project will be led by Cancer Research UK and the Stratified Medicine Proamme and will screen 9,000 cancer patients.Full story -
Samsung Launches Genome Analysis Service, Offers Free Genome
Aug 23, 2011, 03:50 AM by Michael CroftBio-IT World | Samsung SDS is launching beta testing of its new next generation sequencing data analysis service beginning September 1. The service will be in beta testing mode from September to November and will be offering free genome analysis (one genome per researcher) during the testing phase.Full story -
NHGRI Funds Electronic Medical Record Genomics Network
Aug 23, 2011, 00:15 AM by Michael CroftFull storyBio-IT World | Grants worth $25 millions over the next four years from the National Human Genome Research Institute (NHGRI) will support researchers that are part of the Electronic Medical Records and Genomics (eMERGE) network.The grants will fund research to demonstrate that patients' genomic information linked to disease characteristics and symptoms in their electronic medical records can be used to improve their care.
-
Big-Bucks Biology's Broken Business Model
Aug 22, 2011, 08:10 AM by Michael CroftFull storyBio-IT World | The Skeptical Outsider | "Tell me how someone is compensated and I’ll tell you how they’ll behave,” goes the old adage. If non-monetary rewards are considered alongside financial remuneration this pretty much describes why federally funded research in the life sciences is producing less and less bang for more and more bucks. And why the scientific literature is at risk of becoming polluted with overreaching claims, obfuscated shortcomings, and non-reproducible results.
-
Mary Jane's First Genome
Aug 18, 2011, 05:00 AM by Michael CroftBoston Herald | Kevin McKernan, chief developer of the SOLiD platform, has a new venture and has been spending quite a lot of time with the Cannabis plant. Medicinal Genomics has announced the full genome sequencing of Cannabis.Full story -
Stanford Team Reports Advance in Computational Drug Repositioning
Aug 17, 2011, 16:30 PM by Michael CroftWall Street Journal | In a spot of "educated fishing," Atul Butte and colleagues at Stanford University report an innovative way to identify and reposition drugs against diseases they weren't originally designed to combat. The stories of two such repurposed drugs, targeting inflammatory bowel disease and lung cancer, are described in a pair of new papers in the journal Science Translational Medicine.Full story -
Cancer and the Genome: The Bigger Picture
Aug 17, 2011, 03:55 AM by Michael CroftNew York Times | New theories about cancer suggest pseudogenes in the noncoding regions of DNA and microbial gene exchange may be behind the development of some cancers.Full story -
Evolution of the Textbook
Aug 16, 2011, 13:00 PM by Michael CroftHHMI Bulletin | Publishers are beginning to go digital with biology textbooks, pushing boundaries to give students a more personalized, interactive experience.Full story -
DREAM6 Breaks New Ground
Aug 16, 2011, 02:40 AM by Michael CroftFull storyBio-IT World | Roughly five years ago the organizers of DREAM—Dialogue for Reverse Engineering Assessment and Methods—set out to find the best algorithms for inferring biological networks from blinded data sets. It turns out there's no such critter as the perfect algorthm.
-
Halcyon Molecular: Anatomy of a NGS Start-Up
Aug 15, 2011, 09:40 AM by Michael CroftThe Independent | William and Michael Andregg, co-founders of Silicon Valley next-gen sequencing start-up Halcyon Molecular, have given their most extensive interview to date on the motivation and circumstances that led to the launch of this ambitious company in 2008, funded in large part by the 'PayPal mafia.'Full story


